These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 22617565)

  • 1. Role of fibroblast growth factor 19 in the control of glucose homeostasis.
    Schaap FG
    Curr Opin Clin Nutr Metab Care; 2012 Jul; 15(4):386-91. PubMed ID: 22617565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of FGF19 in liver metabolism.
    Kir S; Kliewer SA; Mangelsdorf DJ
    Cold Spring Harb Symp Quant Biol; 2011; 76():139-44. PubMed ID: 21813638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and insulin resistance.
    Schreuder TC; Marsman HA; Lenicek M; van Werven JR; Nederveen AJ; Jansen PL; Schaap FG
    Am J Physiol Gastrointest Liver Physiol; 2010 Mar; 298(3):G440-5. PubMed ID: 20093562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A gut-brain axis regulating glucose metabolism mediated by bile acids and competitive fibroblast growth factor actions at the hypothalamus.
    Liu S; Marcelin G; Blouet C; Jeong JH; Jo YH; Schwartz GJ; Chua S
    Mol Metab; 2018 Feb; 8():37-50. PubMed ID: 29290621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FGFR4 prevents hyperlipidemia and insulin resistance but underlies high-fat diet induced fatty liver.
    Huang X; Yang C; Luo Y; Jin C; Wang F; McKeehan WL
    Diabetes; 2007 Oct; 56(10):2501-10. PubMed ID: 17664243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bile Acids as Hormones: The FXR-FGF15/19 Pathway.
    Kliewer SA; Mangelsdorf DJ
    Dig Dis; 2015; 33(3):327-31. PubMed ID: 26045265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis.
    Kir S; Beddow SA; Samuel VT; Miller P; Previs SF; Suino-Powell K; Xu HE; Shulman GI; Kliewer SA; Mangelsdorf DJ
    Science; 2011 Mar; 331(6024):1621-4. PubMed ID: 21436455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mini-review: endocrine actions of fibroblast growth factor 19.
    Jones S
    Mol Pharm; 2008; 5(1):42-8. PubMed ID: 18179175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic utilities of fibroblast growth factor 19.
    Wu X; Li Y
    Expert Opin Ther Targets; 2011 Nov; 15(11):1307-16. PubMed ID: 21961833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The human gallbladder secretes fibroblast growth factor 19 into bile: towards defining the role of fibroblast growth factor 19 in the enterobiliary tract.
    Zweers SJ; Booij KA; Komuta M; Roskams T; Gouma DJ; Jansen PL; Schaap FG
    Hepatology; 2012 Feb; 55(2):575-83. PubMed ID: 21953282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of FGF19 induced FGFR4 activation in the regulation of glucose homeostasis.
    Wu X; Li Y
    Aging (Albany NY); 2009 Dec; 1(12):1023-7. PubMed ID: 20157585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Enterokine Fibroblast Growth Factor 15/19 in Bile Acid Metabolism.
    Cariello M; Piglionica M; Gadaleta RM; Moschetta A
    Handb Exp Pharmacol; 2019; 256():73-93. PubMed ID: 31123830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Bile Acids in Glucose Metabolism and Their Relation with Diabetes.
    González-Regueiro JA; Moreno-Castañeda L; Uribe M; Chávez-Tapia NC
    Ann Hepatol; 2017 Nov; 16(Suppl. 1: s3-105.):16-21. PubMed ID: 29118282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging role of fibroblast growth factors 15/19 and 21 as metabolic integrators in the liver.
    Cicione C; Degirolamo C; Moschetta A
    Hepatology; 2012 Dec; 56(6):2404-11. PubMed ID: 22753116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curtailing FGF19's mitogenicity by suppressing its receptor dimerization ability.
    Niu J; Zhao J; Wu J; Qiao G; Gu J; Zhou C; Li Q; Ying L; Wang D; Lin H; Li X; Mohammadi M; Huang Z
    Proc Natl Acad Sci U S A; 2020 Nov; 117(46):29025-29034. PubMed ID: 33144503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast growth factor 15/19 (FGF15/19) protects from diet-induced hepatic steatosis: development of an FGF19-based chimeric molecule to promote fatty liver regeneration.
    Alvarez-Sola G; Uriarte I; Latasa MU; Fernandez-Barrena MG; Urtasun R; Elizalde M; Barcena-Varela M; Jiménez M; Chang HC; Barbero R; Catalán V; Rodríguez A; Frühbeck G; Gallego-Escuredo JM; Gavaldà-Navarro A; Villarroya F; Rodriguez-Ortigosa CM; Corrales FJ; Prieto J; Berraondo P; Berasain C; Avila MA
    Gut; 2017 Oct; 66(10):1818-1828. PubMed ID: 28119353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective activation of FGFR4 by an FGF19 variant does not improve glucose metabolism in ob/ob mice.
    Wu X; Ge H; Lemon B; Weiszmann J; Gupte J; Hawkins N; Li X; Tang J; Lindberg R; Li Y
    Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14379-84. PubMed ID: 19706524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Klotho gene family and the endocrine fibroblast growth factors.
    Kurosu H; Kuro-o M
    Curr Opin Nephrol Hypertens; 2008 Jul; 17(4):368-72. PubMed ID: 18660672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulino-mimetic and anti-diabetic effects of vanadium compounds.
    Srivastava AK; Mehdi MZ
    Diabet Med; 2005 Jan; 22(1):2-13. PubMed ID: 15606684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primers on molecular pathways--the insulin pathway.
    Lomberk G; Urrutia R
    Pancreatology; 2009; 9(3):203-5. PubMed ID: 19299910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.